194 related articles for article (PubMed ID: 15454233)
1. Benzothienyloxy phenylpropanamines, novel dual inhibitors of serotonin and norepinephrine reuptake.
Boot JR; Brace G; Delatour CL; Dezutter N; Fairhurst J; Findlay J; Gallagher PT; Hoes I; Mahadevan S; Mitchell SN; Rathmell RE; Richards SJ; Simmonds RG; Wallace L; Whatton MA
Bioorg Med Chem Lett; 2004 Nov; 14(21):5395-9. PubMed ID: 15454233
[TBL] [Abstract][Full Text] [Related]
2. Syntheses and binding studies of new [(aryl)(aryloxy)methyl]piperidine derivatives and related compounds as potential antidepressant drugs with high affinity for serotonin (5-HT) and norepinephrine (NE) transporters.
Orjales A; Mosquera R; Toledo A; Pumar MC; García N; Cortizo L; Labeaga L; Innerárity A
J Med Chem; 2003 Dec; 46(25):5512-32. PubMed ID: 14640559
[TBL] [Abstract][Full Text] [Related]
3. Thiophene derivatives: a new series of potent norepinephrine and serotonin reuptake inhibitors.
Zhang A; Zhou G; Rong SB; Johnson KM; Zhang M; Kozikowski AP
Bioorg Med Chem Lett; 2002 Apr; 12(7):993-5. PubMed ID: 11909701
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and activity of a new class of dual acting norepinephrine and serotonin reuptake inhibitors: 3-(1H-indol-1-yl)-3-arylpropan-1-amines.
Mahaney PE; Vu AT; McComas CC; Zhang P; Nogle LM; Watts WL; Sarkahian A; Leventhal L; Sullivan NR; Uveges AJ; Trybulski EJ
Bioorg Med Chem; 2006 Dec; 14(24):8455-66. PubMed ID: 16973367
[TBL] [Abstract][Full Text] [Related]
5. [Resumption-inhibition in presynaptic action: the medicinal].
Schubert-Zsilavecz M; Stark H
Pharm Unserer Zeit; 2004; 33(4):282-7. PubMed ID: 15287688
[No Abstract] [Full Text] [Related]
6. Milnacipran: a comparative analysis of human monoamine uptake and transporter binding affinity.
Vaishnavi SN; Nemeroff CB; Plott SJ; Rao SG; Kranzler J; Owens MJ
Biol Psychiatry; 2004 Feb; 55(3):320-2. PubMed ID: 14744476
[TBL] [Abstract][Full Text] [Related]
7. Discovery and structure-activity relationships of novel selective norepinephrine and dual serotonin/norepinephrine reuptake inhibitors.
Boot J; Cases M; Clark BP; Findlay J; Gallagher PT; Hayhurst L; Man T; Montalbetti C; Rathmell RE; Rudyk H; Walter MW; Whatton M; Wood V
Bioorg Med Chem Lett; 2005 Feb; 15(3):699-703. PubMed ID: 15664840
[TBL] [Abstract][Full Text] [Related]
8. Further studies on conformationally constrained tricyclic tropane analogues and their uptake inhibition at monoamine transporter sites: synthesis of (Z)-9-(substituted arylmethylene)-7-azatricyclo[4.3.1.0(3,7)]decanes as a novel class of serotonin transporter inhibitors.
Zhang A; Zhou G; Hoepping A; Mukhopadhyaya J; Johnson KM; Zhang M; Kozikowski AP
J Med Chem; 2002 Apr; 45(9):1930-41. PubMed ID: 11960503
[TBL] [Abstract][Full Text] [Related]
9. Neurotransmission of cognition, part 2. Selective NRIs are smart drugs: exploiting regionally selective actions on both dopamine and norepinephrine to enhance cognition.
Stahl SM
J Clin Psychiatry; 2003 Feb; 64(2):110-1. PubMed ID: 12633117
[TBL] [Abstract][Full Text] [Related]
10. Bivalent biogenic amine reuptake inhibitors.
Fandrick K; Feng X; Janowsky A; Johnson R; Cashman JR
Bioorg Med Chem Lett; 2003 Jul; 13(13):2151-4. PubMed ID: 12798324
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.
Park JE; Song C; Choi K; Sim T; Moon B; Roh EJ
Bioorg Med Chem Lett; 2013 Oct; 23(20):5515-8. PubMed ID: 24012181
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of [11C]talopram and [11C]talsupram: candidate PET ligands for the norepinephrine transporter.
McConathy J; Owens MJ; Kilts CD; Malveaux EJ; Camp VM; Votaw JR; Nemeroff CB; Goodman MM
Nucl Med Biol; 2004 Aug; 31(6):705-18. PubMed ID: 15246361
[TBL] [Abstract][Full Text] [Related]
13. 3-(Arylamino)-3-phenylpropan-2-olamines as a new series of dual norepinephrine and serotonin reuptake inhibitors.
Vu AT; Cohn ST; Terefenko EA; Moore WJ; Zhang P; Mahaney PE; Trybulski EJ; Goljer I; Dooley R; Bray JA; Johnston GH; Leiter J; Deecher DC
Bioorg Med Chem Lett; 2009 May; 19(9):2464-7. PubMed ID: 19329313
[TBL] [Abstract][Full Text] [Related]
14. New 1-aryl-3-(4-arylpiperazin-1-yl)propane derivatives, with dual action at 5-HT1A serotonin receptors and serotonin transporter, as a new class of antidepressants.
Martínez-Esparza J; Oficialdegui AM; Pérez-Silanes S; Heras B; Orús L; Palop JA; Lasheras B; Roca J; Mourelle M; Bosch A; Del Castillo JC; Tordera R; Del Río J; Monge A
J Med Chem; 2001 Feb; 44(3):418-28. PubMed ID: 11462981
[TBL] [Abstract][Full Text] [Related]
15. Effect of chronic administration of duloxetine on serotonin and norepinephrine transporter binding sites in rat brain.
Gould GG; Javors MA; Frazer A
Biol Psychiatry; 2007 Jan; 61(2):210-5. PubMed ID: 16650830
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and monoamine transporter affinity of new 2beta-carbomethoxy-3beta-[4-(substituted thiophenyl)]phenyltropanes: discovery of a selective SERT antagonist with picomolar potency.
Tamagnan G; Alagille D; Fu X; Kula NS; Baldessarini RJ; Innis RB; Baldwin RM
Bioorg Med Chem Lett; 2005 Feb; 15(4):1131-3. PubMed ID: 15686927
[TBL] [Abstract][Full Text] [Related]
17. Duloxetine (Cymbalta), a dual inhibitor of serotonin and norepinephrine reuptake.
Bymaster FP; Beedle EE; Findlay J; Gallagher PT; Krushinski JH; Mitchell S; Robertson DW; Thompson DC; Wallace L; Wong DT
Bioorg Med Chem Lett; 2003 Dec; 13(24):4477-80. PubMed ID: 14643350
[TBL] [Abstract][Full Text] [Related]
18. From the selective serotonin transporter inhibitor citalopram to the selective norepinephrine transporter inhibitor talopram: synthesis and structure-activity relationship studies.
Eildal JN; Andersen J; Kristensen AS; Jørgensen AM; Bang-Andersen B; Jørgensen M; Strømgaard K
J Med Chem; 2008 May; 51(10):3045-8. PubMed ID: 18429609
[TBL] [Abstract][Full Text] [Related]
19. Biaryl analogues of conformationally constrained tricyclic tropanes as potent and selective norepinephrine reuptake inhibitors: synthesis and evaluation of their uptake inhibition at monoamine transporter sites.
Zhou J; Zhang A; Kläss T; Johnson KM; Wang CZ; Ye YP; Kozikowski AP
J Med Chem; 2003 May; 46(10):1997-2007. PubMed ID: 12723962
[TBL] [Abstract][Full Text] [Related]
20. Electrophysiological characterization of the effect of long-term duloxetine administration on the rat serotonergic and noradrenergic systems.
Rueter LE; De Montigny C; Blier P
J Pharmacol Exp Ther; 1998 May; 285(2):404-12. PubMed ID: 9580577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
